BCL6 and colitis: discovered that activation of the Bcl6/Syk/BLNK signaling pathway in mice with DSS-induced colitis can regulate the balance of memory B cell subsets, prevent excessive accumulation of inflammatory cells, and mitigate immune damage (11).